Supporting this, another study reported that SPARCL1 is upregulated in liver-specific Apobec1 complementation factor transgenic mice, a model for steatosis, fibrosis, and hepatocellular carcinoma (Blanc et al., 2021). The gene discussed is SPARCL1; the disease is steatosis.